424 related articles for article (PubMed ID: 20814900)
1. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
[TBL] [Abstract][Full Text] [Related]
2. Endostar, a recombined humanized endostatin, inhibits lymphangiogenesis and lymphatic metastasis of Lewis lung carcinoma xenograft in mice.
Dong X; Zhao X; Xiao T; Tian H; Yun C
Thorac Cardiovasc Surg; 2011 Apr; 59(3):133-6. PubMed ID: 21480131
[TBL] [Abstract][Full Text] [Related]
3. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
Fu Y; Chen Y; Luo X; Liang Y; Shi H; Gao L; Zhan S; Zhou D; Luo Y
Biochemistry; 2009 Dec; 48(49):11655-63. PubMed ID: 19877579
[TBL] [Abstract][Full Text] [Related]
4. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.
Fogal V; Sugahara KN; Ruoslahti E; Christian S
Angiogenesis; 2009; 12(1):91-100. PubMed ID: 19225898
[TBL] [Abstract][Full Text] [Related]
5. [Effects of endostatin on the growth and lymphangiogenesis of Lewis lung carcinoma xenograft in mice].
Dong XP; Xiao TH; Meng LB; Yun CH; Tian H
Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(43):3091-3. PubMed ID: 21211334
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
7. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein.
Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y
Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464
[TBL] [Abstract][Full Text] [Related]
10. Endostatin specifically targets both tumor blood vessels and lymphatic vessels.
Zhuo W; Chen Y; Song X; Luo Y
Front Med; 2011 Dec; 5(4):336-40. PubMed ID: 22198745
[TBL] [Abstract][Full Text] [Related]
11. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
12. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
Brideau G; Mäkinen MJ; Elamaa H; Tu H; Nilsson G; Alitalo K; Pihlajaniemi T; Heljasvaara R
Cancer Res; 2007 Dec; 67(24):11528-35. PubMed ID: 18089781
[TBL] [Abstract][Full Text] [Related]
13. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
14. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived lymphangiogenic factors and lymphatic metastasis.
Cao Y; Zhong W
Biomed Pharmacother; 2007 Oct; 61(9):534-9. PubMed ID: 17904785
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human endostatin endostar inhibits tumor growth and metastasis in a mouse xenograft model of colon cancer.
Jia Y; Liu M; Huang W; Wang Z; He Y; Wu J; Ren S; Ju Y; Geng R; Li Z
Pathol Oncol Res; 2012 Apr; 18(2):315-23. PubMed ID: 21938482
[TBL] [Abstract][Full Text] [Related]
17. Paralemmin-1 is expressed in lymphatic endothelial cells and modulates cell migration, cell maturation and tumor lymphangiogenesis.
Albrecht I; Bieri R; Leu A; Granacher P; Hagmann J; Kilimann MW; Christofori G
Angiogenesis; 2013 Oct; 16(4):795-807. PubMed ID: 23709172
[TBL] [Abstract][Full Text] [Related]
18. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
19. Blocking neuropilin-2 function inhibits tumor cell metastasis.
Caunt M; Mak J; Liang WC; Stawicki S; Pan Q; Tong RK; Kowalski J; Ho C; Reslan HB; Ross J; Berry L; Kasman I; Zlot C; Cheng Z; Le Couter J; Filvaroff EH; Plowman G; Peale F; French D; Carano R; Koch AW; Wu Y; Watts RJ; Tessier-Lavigne M; Bagri A
Cancer Cell; 2008 Apr; 13(4):331-42. PubMed ID: 18394556
[TBL] [Abstract][Full Text] [Related]
20. The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.
Song N; Ding Y; Zhuo W; He T; Fu Z; Chen Y; Song X; Fu Y; Luo Y
Angiogenesis; 2012 Dec; 15(4):697-711. PubMed ID: 22711211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
